Salarius Pharmaceuticals Statistics
Total Valuation
SLRX has a market cap or net worth of $1.31 million. The enterprise value is -$2.94 million.
| Market Cap | 1.31M |
| Enterprise Value | -2.94M |
Important Dates
The next estimated earnings date is Thursday, August 8, 2024, after market close.
| Earnings Date | Aug 8, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
SLRX has 597,054 shares outstanding. The number of shares has increased by 75.36% in one year.
| Shares Outstanding | 597,054 |
| Shares Change (YoY) | +75.36% |
| Shares Change (QoQ) | +28.49% |
| Owned by Insiders (%) | 6.08% |
| Owned by Institutions (%) | 4.03% |
| Float | 559,726 |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.36 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.91, with a Debt / Equity ratio of 0.03.
| Current Ratio | 3.91 |
| Quick Ratio | n/a |
| Debt / Equity | 0.03 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -152.20% and return on invested capital (ROIC) is -245.48%.
| Return on Equity (ROE) | -152.20% |
| Return on Assets (ROA) | -111.70% |
| Return on Capital (ROIC) | -245.48% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$4.46M |
| Employee Count | 2 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -81.03% in the last 52 weeks. The beta is 0.97, so SLRX's price volatility has been similar to the market average.
| Beta (5Y) | 0.97 |
| 52-Week Price Change | -81.03% |
| 50-Day Moving Average | 3.54 |
| 200-Day Moving Average | 4.71 |
| Relative Strength Index (RSI) | 23.53 |
| Average Volume (20 Days) | 50,008 |
Short Selling Information
The latest short interest is 31,873, so 5.34% of the outstanding shares have been sold short.
| Short Interest | 31,873 |
| Short Previous Month | 27,295 |
| Short % of Shares Out | 5.34% |
| Short % of Float | 5.69% |
| Short Ratio (days to cover) | 0.72 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -9.25M |
| Pretax Income | -8.92M |
| Net Income | -8.92M |
| EBITDA | -8.91M |
| EBIT | -8.92M |
| Earnings Per Share (EPS) | -$19.92 |
Balance Sheet
The company has $4.37 million in cash and $116,855 in debt, giving a net cash position of $4.26 million or $7.13 per share.
| Cash & Cash Equivalents | 4.37M |
| Total Debt | 116,855 |
| Net Cash | 4.26M |
| Net Cash Per Share | $7.13 |
| Equity (Book Value) | 3.65M |
| Book Value Per Share | 6.11 |
| Working Capital | 3.60M |
Cash Flow
| Operating Cash Flow | -11.03M |
| Capital Expenditures | n/a |
| Free Cash Flow | -11.03M |
| FCF Per Share | -$21.04 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
SLRX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -75.36% |
| Shareholder Yield | -75.36% |
| Earnings Yield | -678.88% |
| FCF Yield | -839.78% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on June 17, 2024. It was a reverse split with a ratio of 1:8.
| Last Split Date | Jun 17, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:8 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |